PUBLIC COMPANY
savePierre Fabre Pharmaceuticals Inc
updated 4mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
🐶 Hiring Signal
News
- Atara, Pierre Fabre resubmit twice-rebuffed cell therapy after FDA flips againEbvallo, which Pierre Fabre Pharmaceuticals and Atara Biotherapeutics are proposing to treat a posttransplant complication, joins a wave of rejected or discouraged therapies on which the FDA has re…biospace · 3d ago
- STAT+: Three biotech updates, including accusations of theft and and a new lobbying leaderBeam Therapeutics has filed a lawsuit alleging one of its former scientists stole intellectual property and used it to co-found a Chinese company that recently made a deal with prominent VC…stat · 3d ago
- Atara, Pierre Fabre's cell therapy to get another shot at FDA approvalThere's new life for a twice-rejected T cell therapy from Atara Biotherapeutics and Pierre Fabre Pharmaceuticals. US regulators are willing to reconsider using a Phase 3 study as the basis for an a…endpoints · 4mo ago
- STAT+: FDA to reconsider treatment for rare cancer after its surprise rejectionThe companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.stat · 4mo ago
comments(0)
5-min edit window · permanent after that